177 related articles for article (PubMed ID: 19231344)
1. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator.
Sakhuja R; Keebler M; Lai TS; McLaughlin Gavin C; Thakur R; Bhatt DL
Am J Cardiol; 2009 Mar; 103(5):735-41. PubMed ID: 19231344
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
3. The current status of interventions aiming at reducing sudden cardiac death in dialysis patients.
de Bie MK; van Dam B; Gaasbeek A; van Buren M; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
Eur Heart J; 2009 Jul; 30(13):1559-64. PubMed ID: 19465437
[TBL] [Abstract][Full Text] [Related]
4. Prevention of sudden cardiac death.
Goldberger JJ
Heart Dis; 2000; 2(4):305-13. PubMed ID: 11728274
[TBL] [Abstract][Full Text] [Related]
5. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
Tung R; Zimetbaum P; Josephson ME
J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
[TBL] [Abstract][Full Text] [Related]
6. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
[TBL] [Abstract][Full Text] [Related]
7. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
Makki N; Swaminathan PD; Hanmer J; Olshansky B
Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
[TBL] [Abstract][Full Text] [Related]
8. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.
Korantzopoulos P; Liu T; Li L; Goudevenos JA; Li G
Europace; 2009 Nov; 11(11):1469-75. PubMed ID: 19812050
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
[TBL] [Abstract][Full Text] [Related]
11. Sudden cardiac death in dialysis: do current guidelines for implantable cardioverter defibrillator therapy apply to patients with end-stage kidney disease?
O'Shaughnessy MM; Lappin DW; Reddan DN
Semin Dial; 2012 May; 25(3):272-6. PubMed ID: 22452711
[TBL] [Abstract][Full Text] [Related]
12. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.
de Bie MK; Lekkerkerker JC; van Dam B; Gaasbeek A; van Buren M; Putter H; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
Curr Med Res Opin; 2008 Aug; 24(8):2151-7. PubMed ID: 18561878
[TBL] [Abstract][Full Text] [Related]
13. Implantable cardioverter-defibrillator and mortality in dialysis patients.
Saravanan P; Davidson NC
Am J Cardiol; 2009 Jun; 103(11):1623-4. PubMed ID: 19463528
[No Abstract] [Full Text] [Related]
14. Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure.
Winslow RD; Pinney S; Fuster V
Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):86-93. PubMed ID: 16446777
[TBL] [Abstract][Full Text] [Related]
15. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
Siddiqui A; Kowey PR
Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
[TBL] [Abstract][Full Text] [Related]
16. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
[TBL] [Abstract][Full Text] [Related]
17. Costs and quality-of-life effects of implantable cardioverter-defibrillators.
Groeneveld PW; Matta MA; Suh JJ; Heidenreich PA; Shea JA
Am J Cardiol; 2006 Nov; 98(10):1409-15. PubMed ID: 17134641
[TBL] [Abstract][Full Text] [Related]
18. Trends in hospitalization for the implantation of cardioverter-defibrillators in the United States, 1990-2005.
Brown DW; Croft JB; Greenlund KJ; Mensah GA; Giles WH
Am J Cardiol; 2008 Jun; 101(12):1753-5. PubMed ID: 18549853
[TBL] [Abstract][Full Text] [Related]
19. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockade in chronic dialysis patients.
Furgeson SB; Chonchol M
Semin Dial; 2008; 21(1):43-8. PubMed ID: 18251957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
